Current concepts and treatment of digitalis toxicity.
D000251:Adenosine Triphosphatases / Q000502:physiology; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy; D001665:Binding Sites; D001692:Biological Transport; D002118:Calcium / Q000502:physiology; D002395:Catecholamines / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects; D002463:Cell Membrane Permeability; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000097:blood / Q000378:metabolism; D004565:Electroconvulsive Therapy; D004594:Electrophysiology; D004976:Ethacrynic Acid / Q000494:pharmacology; D006321:Heart / Q000294:innervation; D006329:Heart Conduction System / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D006934:Hypercalcemia; D000860:Hypoxia; D008012:Lidocaine / Q000627:therapeutic use; D008564:Membrane Potentials; D009119:Muscle Contraction / Q000187:drug effects; D009210:Myofibrils / Q000187:drug effects / Q000502:physiology; D010042:Ouabain / Q000009:adverse effects; D010138:Pacemaker, Artificial; D010672:Phenytoin / Q000627:therapeutic use; D011188:Potassium / Q000097:blood / Q000502:physiology; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D012964:Sodium / Q000502:physiology; D013963:Thyroid Hormones / Q000494:pharmacology
D002395:Catecholamines; D004071:Digitalis Glycosides; D013963:Thyroid Hormones; D010042:Ouabain; D010672:Phenytoin; D008012:Lidocaine; D012964:Sodium; D000251:Adenosine Triphosphatases; D011802:Quinidine; D011342:Procainamide; D004976:Ethacrynic Acid; D011188:Potassium; D002118:Calcium